Market Overview 2023-2028:
The global cardiac prosthetic devices market size reached US$ 6.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
Cardiac prosthetic devices refer to artificial devices that are implanted permanently or temporarily for repairing and replacing damaged heart tissues. Prosthetic heart valves, ventricular assist devices, pacemakers and annuloplasty rings are some of the commonly used cardiac prosthetic devices. Heart valves, including mechanical, tissue (stented/stent-less) and transcatheter valves, are used to prevent retrograde blood flow and leakages. On the other hand, pacemakers are used for maintaining a stable heart rate using electrical impulses. These devices are configured to mimic the normal functioning of cardiovascular organs, and they also aid in preventing further blockages in the heart valves.
Global Cardiac Prosthetic Devices Market Trends and Drivers:
Owing to the sedentary lifestyles led by a majority of the population, coupled with their unhealthy dietary habits, there is an increasing prevalence of cardiovascular diseases (CVDs) and various heart ailments, such as cardiomyopathy and Coronary Artery Disease (CAD) across various regions. In line with this, the rising number of individuals with Marfan syndrome, which affects the heart and lungs, along with other vital organs in the body, is also contributing to the market growth. People with this inherited disease of connective tissues endure a damaged aorta and mitral valve prolapse, which may eventually require cardiac prosthetic device implantation as a treatment option for the effective working of the heart. Furthermore, various technological advancements, such as the development of compact pacemakers and suture-less valve replacements, are acting as another growth-inducing factor. These devices are manufactured using durable and biocompatible raw materials and can be implanted into the patient’s body through minimally invasive (MI) procedures. Other factors, including the growing geriatric population, improving healthcare infrastructure, rising awareness regarding the available treatment for CVDs and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac prosthetic devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
- Mechanical Valve
- Tissue Valve
- Stented Tissue Valve
- Stentless Tissue Valve
- Transcatheter Valve
- Implantable Pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External Pacemakers
Breakup by End-User:
- Hospitals, Clinics and Cardiac Centers
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., Medtronic Inc., Meril Life Sciences Pvt. Ltd., Siemens Healthcare GmbH, Sorin Group, St. Jude Medical Inc., etc.
|Base Year of the Analysis
||Product Type, End-User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Abbott Laboratories, Biotronik, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., Medtronic Inc., Meril Life Sciences Pvt. Ltd., Siemens Healthcare GmbH, Sorin Group and St. Jude Medical Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global cardiac prosthetic devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global cardiac prosthetic devices market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cardiac prosthetic devices market and who are the key players?
- What is the degree of competition in the industry?